Sponsor
Aurobac Therapeutics S.A.S.
29 Avenue Tony Garnier, 69007 Lyon, France
About the sponsor
Research activity is centered on vascular hyperpermeability in the setting of sepsis and septic shock, with attention to the inflammatory and vascular mechanisms that contribute to circulatory instability.
- Vascular hyperpermeability
- Sepsis
- Septic shock
Clinical interest extends to the biological pathways involved in endothelial dysfunction and the restoration of vascular barrier integrity.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.